We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$1.76B
AUM Growth
-$218M
Cap. Flow
-$265M
Cap. Flow %
-15.02%
Top 10 Hldgs %
22.75%
Holding
203
New
31
Increased
55
Reduced
62
Closed
55

Top Buys

Rank Stock Value
1
RNG icon
RingCentral
RNG
+$36.8M
2
ACHC icon
Acadia Healthcare
ACHC
+$30.7M
3
BILL icon
BILL Holdings
BILL
+$20.8M
4
OMC icon
Omnicom Group
OMC
+$15.9M
5
EQX icon
Equinox Gold
EQX
+$14.9M

Top Sells

Rank Stock Value
1
DNB
Dun & Bradstreet
DNB
+$33.6M
2
SLB icon
SLB Ltd
SLB
+$23.7M
3
MTCH icon
Match Group
MTCH
+$22.9M
4
MUR icon
Murphy Oil
MUR
+$19.4M
5
LYFT icon
Lyft
LYFT
+$18.8M

Sector Composition

Rank Sector Weight
1 Technology 25.6%
2 Consumer Discretionary 17.8%
3 Healthcare 16.38%
4 Industrials 9.22%
5 Materials 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRNT
26
DELISTED
Verint Systems
VRNT
$21M 1.19%
1,066,142
-89,390
-8% -$1.56M
NGD
27
DELISTED
New Gold Inc
NGD
$20.9M 1.19%
4,227,089
+815,337
+24% +$3.35M
EQX icon
28
Equinox Gold
EQX
$13.5B
$20.8M 1.18%
3,618,084
+2,297,552
+174% +$14.9M
CHRD icon
29
Chord Energy
CHRD
$7.39B
$20.7M 1.17%
213,665
-143,793
-40% -$13.7M
BPOP icon
30
Popular Inc
BPOP
$11.1B
$20.2M 1.14%
182,968
+13,785
+8% +$1.36M
IQV icon
31
IQVIA
IQV
$39.3B
$20.1M 1.14%
127,282
+39,220
+45% +$5.9M
ENOV icon
32
Enovis
ENOV
$1.53B
$18.2M 1.03%
580,964
+131,187
+29% +$4.34M
MYE icon
33
Myers Industries
MYE
$1.29B
$17.7M 1%
1,221,555
+203,439
+20% +$2.48M
DOLE icon
34
Dole
DOLE
$1.32B
$17.3M 0.98%
1,239,640
+243,785
+24% +$3.45M
VSH icon
35
Vishay Intertechnology
VSH
$5.43B
$17M 0.97%
1,072,739
+201,268
+23% +$2.8M
DMC
36
Del Monte Corp
DMC
$1.45B
$15.7M 0.89%
485,350
+89,361
+23% +$2.94M
SBH icon
37
Sally Beauty Holdings
SBH
$1.58B
$15.6M 0.89%
1,685,036
-204,274
-11% -$1.76M
OMC icon
38
Omnicom Group
OMC
$23.4B
$15.5M 0.88%
+215,169
New +$15.9M
RPD icon
39
Rapid7
RPD
$773M
$15.2M 0.86%
657,519
+578,470
+732% +$13.7M
JACK icon
40
Jack in the Box
JACK
$335M
$15.2M 0.86%
869,231
+357,277
+70% +$8.04M
SSTK icon
41
Shutterstock
SSTK
$219M
$15M 0.85%
790,402
-94,620
-11% -$1.66M
COP icon
42
ConocoPhillips
COP
$141B
$14.8M 0.84%
+165,053
New +$14.9M
LEG icon
43
Leggett & Platt
LEG
$1.31B
$14.5M 0.82%
1,627,227
-365,092
-18% -$3.14M
FIVE icon
44
Five Below
FIVE
$13.5B
$14.5M 0.82%
110,360
-119,898
-52% -$11.7M
MATV icon
45
Mativ Holdings
MATV
$711M
$14.5M 0.82%
2,119,976
-101,621
-5% -$586K
IOVA icon
46
Iovance Biotherapeutics
IOVA
$2.87B
$14.3M 0.81%
8,294,663
+2,804,864
+51% +$6.98M
IAS
47
DELISTED
Integral Ad Science
IAS
$13.1M 0.75%
1,580,066
-69,917
-4% -$533K
FHI icon
48
Federated Hermes
FHI
$4.72B
$13.1M 0.74%
295,097
+8,212
+3% +$338K
ABM icon
49
ABM Industries
ABM
$2.84B
$12.6M 0.72%
+267,850
New +$12.9M
TDOC icon
50
Teladoc Health
TDOC
$1.3B
$12.6M 0.72%
1,446,362
+119,234
+9% +$864K
1
2
3 4 5

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return

Invenomic Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Invenomic Capital Management held 203 positions worth $1.76B, down 11% from $1.98B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Invenomic Capital Management withdrew a net $265M in Q2 2025, closing 55 positions and reducing 62 holdings. Its most notable exit was Dun & Bradstreet, an estimated $33.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Invenomic Capital Management opened a new position in RingCentral worth $40.5M.

  • Invenomic Capital Management's largest Q2 2025 buy was RingCentral: 1,427,359 shares worth $40.5M.
  • Invenomic Capital Management added most to Acadia Healthcare in Q2 2025, an estimated $30.7M increase.
  • Invenomic Capital Management's biggest Q2 2025 reduction was Match Group, cutting an estimated $22.9M.
  • Invenomic Capital Management fully exited Dun & Bradstreet in Q2 2025, selling an estimated $33.6M.
  • Invenomic Capital Management's ten largest holdings make up 23% of its $1.76B portfolio in Q2 2025.
  • Invenomic Capital Management opened 31 new positions and closed 55 in Q2 2025.
  • Invenomic Capital Management's portfolio value fell 11% quarter-over-quarter to $1.76B.

Based on Invenomic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.